Name of disease |
COVID-19 |
[35] |
Caused by |
SARS-CoV-2 |
[35–37] |
Virus genus |
β-coronavirus |
[14] |
Virus composition |
RNA, Spike protein, β-coronavirus, and hemagglutinin |
[38] |
Virus target |
Respiratory system |
|
Functional receptor |
ACE-2 |
[28] |
Mode of transmission |
Contact, respiratory droplets, fecal oral route, and fomites |
|
Incubation period |
2–14 days |
[39] |
Average age affected |
46% of cases occur in adults |
|
Classic symptoms |
Fever, cough, sore throat, and shortness of breath |
[40] |
Complications |
Pneumonia, ARDS |
|
Mortality rate |
>3%; increases with age and co-morbidities |
[41] |
Investigation/findings |
CT chest, lymphocytopenia |
|
Diagnosis |
Identification of viral RNA by PCR |
[2] |
Treatment |
Supportive care including antiviral drugs |
|
Vaccines |
Under clinical trials in selected countries |
|
Mode of reduction |
Social distancing, avoidance of close contact, good personal hygiene, personal protective equipment, sheltering at home, isolation of identified cases |
|